Summary
Ascletis Inc. (Ascletis) is a biopharmaceutical company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of clinical proof-of-concept, global partnering and research and development services of novel therapeutics for life-threatening diseases. Its research and development services comprise product indication, lead development, pre clinical studies and phase development services. Ascletis’s development pipelines comprise danoprevirs, PPI, ALN-VSP and others. It has its presence in the US and China. The company offers discovery and development of important therapeutics with both small molecule and biologics approaches. Ascletis is headquartered in Chapel Hill, North Carolina, the US.
Ascletis Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ascletis Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ascletis Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Ascletis Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ascletis Raises USD35 Million in Venture Financing 10
Ascletis Raises US$50 Million In First Tranche Of Series A Financing 11
Partnerships 12
Roche Enters Into Agreement With Ascletis To Develop HCV Drug Danoprevir 12
Ascletis Enters Into Agreement With Minsheng Pharma For R&D 13
Licensing Agreements 14
Ascletis Enters into Licensing Agreement with Presidio Pharma for PPI-668 14
Ascletis Enters Into Licensing Agreement With Janssen For TMC310911 15
Ascletis Inc. - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Ascletis Inc., Pharmaceuticals & Healthcare, Key Facts 1
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ascletis Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ascletis Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Ascletis Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Ascletis Raises USD35 Million in Venture Financing 10
Ascletis Raises US$50 Million In First Tranche Of Series A Financing 11
Roche Enters Into Agreement With Ascletis To Develop HCV Drug Danoprevir 12
Ascletis Enters Into Agreement With Minsheng Pharma For R&D 13
Ascletis Enters into Licensing Agreement with Presidio Pharma for PPI-668 14
Ascletis Enters Into Licensing Agreement With Janssen For TMC310911 15
Ascletis Inc., Key Competitors 16
Ascletis Inc., Key Employees 17
Ascletis Inc., Other Locations 18
List of Figures
Ascletis Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ascletis Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ascletis Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8